There could be many reasons as to why brain tumors can come about, some of them easier believe than others. However, if you were to ask me what a solid cause for a growth to occur in the brain could be, I would be stumped. The truth of the matter is that there is no clear answer but is it possible that a mutated gene can shed some much needed light on the situation? The potential seems to be there, if a recent report is anything to go by.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
About the Author:
For further knowledge regarding brain tumors, please go to Voices against Brain Cancer for specifics.
0 comments:
Post a Comment